Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malmberg, K. A.
Right arrow Articles by Ryden, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malmberg, K. A.
Right arrow Articles by Ryden, L. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 17, Issue 9 1007-1014, Copyright © 1994 by American Diabetes Association


ARTICLES

Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. A report from the multicenter trial: DIGAMI

KA Malmberg, S Efendic and LE Ryden
Department of Cardiology, Karolinska Hospital, Stockholm, Sweden.

OBJECTIVE--To investigate the effect of insulin-glucose infusion on metabolic control and hypoglycemic episodes and its feasibility and safety in patients with diabetes and myocardial infarction (MI) compared with conventional treatment. RESEARCH DESIGN AND METHODS--Of 327 patients with suspected acute MI 158 were randomized to insulin-glucose infusion for at least 24 h and 169 received conventional therapy. We determined the 24-h blood glucose profile in the infusion group, the degree of metabolic control, hypoglycemic events, and in-hospital complications within the two study groups. RESULTS--Blood glucose fell from 14.6 +/- 2.9 to 9.2 +/- 2.9 mM during the first 24 h in patients receiving insulin-glucose and from 15.8 +/- 4.3 to 12.0 +/- 4.4 mM in control patients (P < 0.01). Serum potassium decreased 0.21 +/- 0.56 mM in the infusion group (P < 0.001) and 0.11 +/- 0.59 mM in the control group (P < 0.05). The difference between the groups was not significant. Twenty-eight of the 158 patients developed an episode of hypoglycemia (blood glucose < 3.0 mM) during the insulin-glucose infusion. There were no significant differences in the number of episodes of ventricular tachyarrhythmias or in ischemic events between patients with and without hypoglycemia. CONCLUSIONS--The protocol outlined in this study gives more rapid and better metabolic control than does conventional treatment. This treatment seems to be a feasible alternative for clinical attempts. Before it can be recommended for general use, the impact on mortality needs to be evaluated.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Eur Heart JHome page
A.-M. Svensson, D. K. McGuire, P. Abrahamsson, and M. Dellborg
Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events
Eur. Heart J., July 1, 2005; 26(13): 1255 - 1261.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. B. Davidson
Early Insulin Therapy for Type 2 Diabetic Patients: More Cost Than Benefit
Diabetes Care, January 1, 2005; 28(1): 222 - 224.
[Full Text] [PDF]


Home page
Diabetes CareHome page
A. Ceriello
Insulin, Glycemic Control, and C-Reactive Protein During Myocardial Infarction
Diabetes Care, December 1, 2004; 27(12): 3017 - 3018.
[Full Text] [PDF]


Home page
Diabetes CareHome page
S. Clement, S. S. Braithwaite, M. F. Magee, A. Ahmann, E. P. Smith, R. G. Schafer, and I. B. Hirsch
Management of Diabetes and Hyperglycemia in Hospitals
Diabetes Care, February 1, 2004; 27(2): 553 - 591.
[Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
Aspects of Blood Pressure, Lipid, and Glycemic Treatment
Diabetes Care, January 1, 2004; 27(1): 264 - 269.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. C. C. van der Horst, F. Zijlstra, A. W. J. van't Hof, C. J. M. Doggen, M.-J. de Boer, H. Suryapranata, J. C. A. Hoorntje, J.-H. E. Dambrink, R. O. B. Gans, H. J. G. Bilo, et al.
Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: The glucose-insulin-potassium study: a randomized trial
J. Am. Coll. Cardiol., September 3, 2003; 42(5): 784 - 791.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
V. M. Montori, B. R. Bistrian, and M. M. McMahon
Hyperglycemia in Acutely Ill Patients
JAMA, November 6, 2002; 288(17): 2167 - 2169.
[Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
M. Fisher
Diabetes mellitus, insulin-glucose infusion in acute myocardial infarction (DIGAMI) study
The British Journal of Diabetes & Vascular Disease, September 1, 2002; 2(5): 382 - 383.
[PDF]


Home page
BMJHome page
R. Williams, B M. Fisher, and K. McLaughlin
Intensive insulin treatment after acute myocardial infarction in diabetes mellitus
BMJ, August 30, 1997; 315(7107): 544 - 544.
[Full Text]


Home page
BMJHome page
K. Malmberg
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
BMJ, May 24, 1997; 314(7093): 1512 - 1512.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1994 by the American Diabetes Association.